Estabrook Capital Management lessened its stake in shares of Nutrien Ltd (NYSE:NTR) by 27.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 640 shares of the company’s stock after selling 244 shares during the period. Estabrook Capital Management’s holdings in Nutrien were worth $30,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Litman Gregory Asset Management LLC acquired a new stake in Nutrien during the 4th quarter worth about $26,000. PRW Wealth Management LLC purchased a new position in Nutrien during the 4th quarter valued at about $30,000. Proficio Capital Partners LLC grew its stake in Nutrien by 38.3% during the 4th quarter. Proficio Capital Partners LLC now owns 902 shares of the company’s stock valued at $42,000 after acquiring an additional 250 shares in the last quarter. Capital Investment Advisory Services LLC purchased a new position in Nutrien during the 4th quarter valued at about $53,000. Finally, Resources Investment Advisors Inc. purchased a new position in Nutrien during the 4th quarter valued at about $59,000. Hedge funds and other institutional investors own 65.74% of the company’s stock.
Shares of NYSE NTR opened at $53.66 on Friday. The firm has a market capitalization of $32.42 billion, a P/E ratio of 19.95, a PEG ratio of 1.69 and a beta of 0.79. Nutrien Ltd has a one year low of $43.96 and a one year high of $58.99.
The company also recently announced a quarterly dividend, which will be paid on Thursday, April 18th. Investors of record on Friday, March 29th will be paid a $0.43 dividend. The ex-dividend date is Thursday, March 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 3.21%. Nutrien’s payout ratio is 63.94%.
NTR has been the topic of several research analyst reports. BMO Capital Markets raised Nutrien from a “market perform” rating to an “outperform” rating in a research note on Tuesday, January 8th. Barclays reaffirmed a “buy” rating on shares of Nutrien in a research note on Sunday, February 10th. Citigroup lowered their target price on Nutrien from $66.00 to $56.00 and set a “buy” rating on the stock in a research note on Monday, January 7th. Raymond James reissued a “strong-buy” rating and issued a $70.00 price target on shares of Nutrien in a research note on Thursday, February 7th. Finally, JPMorgan Chase & Co. started coverage on Nutrien in a research note on Thursday, December 13th. They issued a “neutral” rating and a $50.00 price target for the company. Seven investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Nutrien currently has a consensus rating of “Buy” and a consensus price target of $61.69.
WARNING: “Nutrien Ltd (NTR) Holdings Cut by Estabrook Capital Management” was first posted by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://dakotafinancialnews.com/2019/03/15/nutrien-ltd-ntr-holdings-cut-by-estabrook-capital-management.html.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.
Featured Article: What is insider trading?
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd (NYSE:NTR).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.